Working @ Immatics

Associate Director Project Management / Project Lead*

Permanent employee, Full-time · Tuebingen or Munich (Germany)

Overview
We are currently seeking an experienced Project Lead* to strengthen our Project Management and Translational Development (PMTD) department in the research and development of innovative immunotherapeutic products. You will work at one of our sites in Houston, TX, or Tübingen or Munich (Germany) in an interdisciplinary and international environment with colleagues from R&D as well as various other departments across the Company.
Your mission
The PMTD department oversees preclinical and clinical projects from our own drug development pipeline and collaboration programs with biotech and pharma partners. As Project Lead you will be responsible for development project(s) of high impact and visibility and you will be accountable for the achievement of project objectives and milestones. You will work closely with the Development Lead and Department Heads to steer the project towards success. As Project Lead you will mentor the Project Manager and support their role in the successful management of the project team. Your responsibilities will include but are not limited to the following tasks:
 
  • Manage the interdisciplinary R&D team to successfully achieve the project goals on time and on budget
  • Coordinate the cooperation of all departments involved – in Germany as well as in the US
  • Address research and development tasks with the experts, develop and present convincing solutions and concepts
Your profile
You have successfully completed your doctorate in the field of life sciences, medicine, pharmacy, or a comparable education. You have significant experience in drug development (5+ years) and the immuno-oncology space including insights into the specifics of cellular therapies (TCR-T or CAR-T) and early phase clinical trials. You have a strong science driven analytical thinking and the desire and capabilities to motivate and manage cross-functional teams in a matrix structure towards achieving the strategic project goals. 
 
Your scientific mindset, your excellent organizational and communication skills and your insights into drug development enable you to successfully cope with your tasks. Implementing strategic aspects and overall business needs into your daily work is perfectly natural to you. You are open to dynamically developing requirements and demonstrate a high degree of flexibility. You enjoy working in an environment where excellence is a constant requirement. You are driven by your passion for innovation and science to advance the development of our drug candidates into clinical applications that matter for patients.
Why us?
We are a committed and inspired team and cherish the collegial, highly motivated and family-friendly atmosphere within Immatics. Our culture allows for a high level of originality, independent thinking and initiative. We believe in supporting our employees’ professional and social skills: We enable them to join conferences and trainings as well as to enjoy our Immatics benefits – e.g. job bike, job ticket, Health Programs, childcare benefits, relocation allowance, Company summer and winter events.
Notice
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
About Us
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.

This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.